Trials / Enrolling By Invitation
Enrolling By InvitationNCT06472817
Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men
iCCARE Project # 4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.
Detailed description
PRIMARY OBJECTIVE: I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II) OUTLINE: This is an observational study. AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study. AIM II: Participants complete an interview in person, over the phone, or via zoom on study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2023-09-05
- Primary completion
- 2026-09-11
- Completion
- 2026-09-11
- First posted
- 2024-06-25
- Last updated
- 2026-01-21
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06472817. Inclusion in this directory is not an endorsement.